| 2023/03/24 17:30:21 | |
|---|---|
| Price | |
| 61.06 CHF | |
| Difference | -2.30% (-1.44) |
General attributes
| ISIN | CH0432492467 |
| Symbol | ALC |
| Exchange | SIX Swiss Exchange |
| Currency | CHF |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 30,111 EUR |
| Benchmark | SWISS MARKET INDEX |
Market data
| Bid (Bid size) | 61.04 CHF (53,197) |
| Ask (Ask size) | 61.06 CHF (767) |
| Open | 61.70 CHF |
| High | 62.08 CHF |
| Low | 60.52 CHF |
| Close (prev. day) | 62.50 CHF |
| VWAP | 61.194013 CHF |
| Volume (pcs) | 1,123,052 |
| Trading volume | 68,724,058.81 |
| Number of trades | 3,974 |
| Last size | 1,696 |
Futures and Options
| Related Futures | 30 |
| Related Options | - |
PDF Downloads
| Company report: ALCON AG |  |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Recent research
| Date | Headline | Download | |
| 2023/03/16 |
|
Global Equity Ratings |
|
| 2023/03/10 |
|
Global Equity Ratings |
|
| 2023/02/27 |
|
Global Equity Ratings |
|
| 2023/02/07 |
|
Global Equity Ratings |
|
| 2023/01/30 |
|
Global Equity Ratings |
|
| 2023/03/24 17:30:21 | |
|---|---|
| Price | |
| 61.06 CHF | |
| Difference | -2.30% (-1.44) |
General attributes
| ISIN | CH0432492467 |
| Symbol | ALC |
| Exchange | SIX Swiss Exchange |
| Currency | CHF |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 30,111 EUR |
| Benchmark | SWISS MARKET INDEX |
Market data
| Bid (Bid size) | 61.04 CHF (53,197) |
| Ask (Ask size) | 61.06 CHF (767) |
| Open | 61.70 CHF |
| High | 62.08 CHF |
| Low | 60.52 CHF |
| Close (prev. day) | 62.50 CHF |
| VWAP | 61.194013 CHF |
| Volume (pcs) | 1,123,052 |
| Trading volume | 68,724,058.81 |
| Number of trades | 3,974 |
| Last size | 1,696 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | +4.73% | -13.64% | +39.98% |
| Perf (abs.) | +2.76 | -9.64 | +17.44 |
| Beta | 1.16 | 1.14 | 1.21 |
| Volatility | 25.74 | 28.02 | 29.09 |
Scale: ABS REL
Instrument
Add Benchmark:
Information about previous performance does not guarantee future performance.Source: FactSet
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 61.90 CHF (1,183,048) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 64.29 CHF (1,476,747) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 64.80 CHF (993,132) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 66.22 CHF (879,531) |
| YTD High | date | 70.86 CHF (2023/02/02) |
| YTD Low | date | 58.30 CHF (2023/03/13) |
| 52 Weeks High | date | 77.58 CHF (2022/04/21) |
| 52 Weeks Low | date | 55.22 CHF (2022/09/29) |
All listings for ALCON AG
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Tradegate | 2019/06/28 | 22:26 | 54.15 EUR | 0.38 | 102 |
| SIX Swiss Exchange | 2023/03/24 | 17:30 | 61.06 CHF | 68.72 | 3,974 |
| NYSE | 2023/03/24 | 21:00 | 67.49 USD | 132.71 | 23,914 |
| London Stock Exchange European Trade Reporting | 2023/03/24 | 17:20 | 61.775 CHF | 0.09 | 6 |
| Hanover | 2019/06/28 | 08:00 | 52.91 EUR | 0.00 | 2 |
| Hamburg | 2019/06/28 | 12:29 | 53.43 EUR | 0.01 | 4 |
| Frankfurt | 2019/06/28 | 17:10 | 54.07 EUR | 0.06 | 23 |
| Duesseldorf | 2019/06/28 | 11:10 | 53.10 EUR | 0.00 | 2 |
| Berlin | 2019/06/28 | 18:47 | 54.31 EUR | 0.00 | 7 |
| BX Swiss | 2023/03/23 | 18:00 | 61.883 CHF | 0.00 | 1 |
Company Logo
Contact Details
| ALCON AG |
| - - |
| Chemin de Blandonnet 8, Vernier - 1214 Genf |
| Telefon: +41-817-293-04-50 |
| Fax: +41-817-916-26-52 |
| E-mail: - |
PDF Downloads
| Company report: ALCON AG | |
Company Profile
Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the following segments: Surgical and Vision Care. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Geneva, Switzerland. |
Members of Management Board
| David Endicott | Chairman of Managing Board |
| Ian Bell | Member of Executive Committee |
| Laurent Attias | Member of Executive Committee |
| Rajkumar Narayanan | Member of Executive Committee |
| Sergio Duplan | Member of Executive Committee |
| Sue-Jean Lin | Member of Executive Committee |
| Tim Stonesifer | Member of Executive Committee |
Board of directors
| Arthur Cummings | Member of the administrative board |
| Bono Raquel Cruz | Member of the administrative board |
| Dieter Spälti | Member of the administrative board |
| D. Grossman | Member of the administrative board |
| Ines Pöschel | Member of the administrative board |
| Karen May | Member of the administrative board |
| Lynn Bleil | Member of the administrative board |
| Scott Maw | Member of the administrative board |
| Thomas Heinrich Glanzmann | Member of the administrative board |
| F. Ball | Chairman of the administrative boar |